- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
4 result(s) found for: Trace elements.
Displaying page 1 of 1.
EudraCT Number: 2005-004541-34 | Sponsor Protocol Number: 21092005 | Start Date*: 2006-02-14 |
Sponsor Name:South Manchester University Healthcare Trust | ||
Full Title: The Effect of Enteral Administration of Synbiotics Upon Infection Rates in Major Burns | ||
Medical condition: Major burn injuries: Thermal related trauma with burn injury involving significant proportions of the total body surface area, as defined by age: Adults (>=17 years old): >= 15% body surface area ... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-003185-33 | Sponsor Protocol Number: INRCA-02-2011 | Start Date*: 2011-10-13 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE DI RICOVERO E CURA PER ANZIANI IRCCS | |||||||||||||
Full Title: Prospective, controlled, randomized, blind study to evaluate the effects of intramuscular-paravertebral injections of an oxygen-ozone (O2-O3) mixture in patients with lumbar pain aged 65 or older | |||||||||||||
Medical condition: subjects aged 65 or older with lumbar pain and discopathy for at least 6 weeks | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001731-30 | Sponsor Protocol Number: CDP791-002 | Start Date*: 2005-07-25 |
Sponsor Name:UCB Celltech | ||
Full Title: A Two-Part, Open Label Phase II Trial: Part One, Dose Escalation Safety; Part Two, Randomized/Comparing CDP791 (10 or 20 mg/kg) Plus Carboplatin/Paclitaxel With Carboplatin/Paclitaxel Alone in Sub... | ||
Medical condition: Non squamous non small cell lung cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006715-22 | Sponsor Protocol Number: CP12-0708 | Start Date*: 2008-12-18 | ||||||||||||||||
Sponsor Name:ImClone LLC | ||||||||||||||||||
Full Title: A Phase 2, Open-label Study of IMC-1121B in Combination with Paclitaxel and Carboplatin as First-line Therapy in Patients with Stage IIIB/IV Non-small Cell Lung Cancer | ||||||||||||||||||
Medical condition: Stage IIIB/IV Non-small Cell Lung Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
